Subscribe
Close
  • Free for qualified executives and consultants to industry

  • Receive quarterly issues of Area Development Magazine and special market report and directory issues

Renew

Elanco Expands-Renovates Elwood, Kansas, Operations

08/21/2024
Elanco, a company that develops products and solutions for the animal health industry, plans to expand its operations in Elwood, Kansas. The $130 million project is expected to create approximately 70 jobs in Doniphan County over the next two years.

The investment will include the renovation of the company’s existing facility which currently manufactures and ships its Canine Parvovirus Monoclonal Antibody and will be the flagship location for future monoclonal antibody manufacturing.

“Expanding the capabilities at our Elwood manufacturing site is a critical step toward executing the most exciting pipeline in Elanco’s 70-year history,” Elanco Manufacturing and Quality Executive Vice President Grace McArdle said. “In partnership with our Elanco research and development colleagues, this site plays a key role in delivering solutions that are transforming the way veterinarians and pet owners care for the world’s animals. We appreciate the commitment of the State of Kansas, Doniphan County, and the City of Elwood to help pets live longer, healthier, more active lives.”

Elanco Animal Health Incorporated is a pharmaceutical company which produces medicines and vaccinations for pets and livestock. The company was a subsidiary of Eli Lilly and Company, before being divested.

“Sitting in the heart of the Animal Health Corridor, Kansas is a powerhouse in this critical sector – attracting companies from across the nation and around the world,” Lieutenant Governor and Secretary of Commerce David Toland noted “Elanco is an excellent example of the top-notch employers the Kelly-Toland administration is committed to partnering with as we grow the state's economy.”

Exclusive Research